Comparative study of Papaya Vs Normal Saline Dressing in healing of Ulcers by Vimalakaran, B
1 
 
Comparative study of Papaya Vs Normal 
Saline Dressing in healing of Ulcers 
Dissertation submitted 
To 
THE TAMILNADU DR. M.G.R. MEDICAL 
UNIVERSITY, CHENNAI 
                          In partial fulfillment of the regulations for the award of the degree of  
M.S (General Surgery) 
Branch-I 
 
Government Kilpauk Medical College 
Chennai:   April-2015 
2 
 
 
DECLARATION BY THE CANDIDATE 
 
I hereby declare that this dissertation titled “COMPARATIVE STUDY OF 
PAPAYA VS NORMAL SALINE DRESSING IN HEALING OF ULCERS” 
is a bonafide and genuine research work carried out by me under the guidance of 
Prof. Dr. USHA DORAIRAJAN MS, FRCS, Department of General Surgery, 
Kilpauk Medical College, Chennai-10. 
This dissertation is submitted to THE TAMILNADU DR. M.G.R. 
MEDICAL UNIVERSITY CHENNAI in partial fulfillment of the degree of 
M.S. General Surgery examination to be held in April 2015. 
 
 
 
 
 
 
 
 
 
 
 
Date:  
 
 
Place:                   DR B. VIMALAKARAN.  
 
   
  
3 
 
CERTIFICATE 
 
 
This is to certify that this dissertation is the bonafide work of 
 
DR B. VIMALAKARAN 
 
On 
 
 
“COMPARATIVE STUDY OF PAPAYA VS NORMAL SALINE DRESSING 
IN HEALING OF ULCERS’’ 
 
 
During his course in M.S. General Surgery from May 2012 to April 2015 at Government 
Kilpauk Medical College, Chennai-10. 
 
 
 
 
 
Prof. P.N.SHANMUGASUNDARAM, MS.,   Prof. USHA DORAIRAJAN,MS,FRCS., 
Professor and Head of the Department,    Professor of General Surgery, 
Department of General Surgery,     Department of General Surgery, 
Govt Kilpauk Medical College,     Govt Kilpauk Medical College, 
Chennai-10       Chennai-10 
 
 
 
 
 
 
Prof. N.GUNASEKARAN, M.D, D.T.C.D., 
DEAN 
Govt. Kilpauk Medical College, 
Chennai-10 
 
  
4 
 
CERTIFICATE BY THE GUIDE 
 
This is to certify that the dissertation titled “COMPARATIVE STUDY OF 
PAPAYA VS NORMAL SALINE DRESSING IN HEALING OF ULCERS’’ 
is a bonafide research work done by Dr B. Vimalakaran, post graduate in M.S. 
General Surgery, Kilpauk Medical College, Chennai-10 under my direct guidance 
and supervision in my satisfaction, in partial fulfillment of the requirements for the 
degree of M.S. General Surgery. 
 
 
 
 
 
Date:      Prof. Dr. Usha Dorairajan, MS, FRCS., 
Place:      Professor of General Surgery, 
      Kilpauk Medical College, Chennai-10 
  
5 
 
ACKNOWLEDGEMENT 
                   I avail this opportunity to express my profound earnest gratitude to my 
esteemed teacher and guide Prof.Dr.Usha Dorairajan, M.S,FRCS., Professor of 
General Surgery,  Kilpauk Medical College and Hospital for her unflinching 
support, valuable guidance and encouragement provided to me during this study, 
without which it would not have been possible for me to complete this work. 
 
                  I express my sincere thanks and gratitude to my esteemed teacher 
Prof.Dr.P.N.Shanmugasundaram, M.S., Head of Department of General Surgery, 
Kilpauk Medical College and Hospital for his expert guidance and immense 
support during the course of this study. 
 
                   I would like to thank my teachers Dr.V.Vijayalakshmi, M.S., 
Dr.N.B.Thanmaran, M.S., Dr.A.K.Kalpanadevi, M.S., Dr.K.Ramachandran, M.S., 
for their continuous support and encouragement. 
 
                  It is with immense honour and pleasure that I take this opportunity to 
thank our Dean, Prof.N.Gunasekaran M.D, D.T.C.D., for his support, 
encouragement and facilities provided during the course of this dissertation. 
6 
 
                  I am grateful to all my patients for their cooperation without which this 
study would not have been possible. I am deeply indebted to the Government of 
Tamilnadu for giving me this opportunity. 
 
 
(Dr.B.Vimalakaran) 
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 
 
ABSTRACT 
 
 
AIM:    
           To compare the effectiveness of papaya and normal saline in healing of 
ulcers.To evaluate the role of papaya dressing in wound debridement, granulation 
tissue formation,  reduction in ulcer size and ulcer healing. 
 
BACKGROUND: 
             Wet to dry normal saline mechanical debridement is the most common, 
cost effective debridement method which is used widely, in our hospital setup also 
in management of wound care. Papaya has been a enzymatic debriding agent 
which is in use for many years. There has been various review articles and studies 
on the debriding properties of papaya in western population and diabetic rats.This 
study was conducted to compare the efficacy of two debriding agents : enzymatic 
debridement with papaya and wet to dry normal saline mechanical debridement on 
diabetic wounds, sloughed infected wounds and in post operative wound 
dehiscence. 
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MATERIALS AND METHODS: 
                 This is a comparative interventional study of 100 patients done at 
Government Kilpauk Medical College Hospital Chennai between August 2013 to 
August 2014.patients were selected and randomized into two groups Group I – 
treated with papaya and Group II with normal saline. Patients were clinically 
assessed at the time of inclusion and daily dressing was done. Patients were 
assessed weekly for 4 weeks and response noted regarding slough reduction, 
granulation tissue formation, reduction in ulcer size and overall response to 
treatment. Additional treatment and follow up upto 3 months were recorded. 
 
RESULTS: 
                      Papaya is a better and efficacious debriding agent in comparison to 
wet to dry normal saline dressing and it also promotes faster granulation tissue 
formation. Overall response to treatment with papaya is good.  
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INTRODUCTION 
 
 
Wound management has been a fundamental part of general surgical 
practice since ancient times. Chronic non-healing wounds pose a remarkable 
challenge to health professionals and drain our resources. In recent years, 
prevalence of diabetic foot ulcers is growing at epidemic proportion in India and 
worldwide and they have become the major contributors of chronic non-healing 
wounds. 
 
  Although wound management is a day-to-day activity in surgical wards, 
there is always scope for betterment of our surgical practice. Therapeutic strategies 
have been evolving over the years and there are varieties of dressing options 
available for wound bed preparation, wound cover, activation of wound healing 
and repair. Technological advancements have also resulted in topical applications 
of recombinant platelet derived growth factors and bio engineered skin substitutes 
for skin coverage in wound management. 
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The sequence of wound repair is controlled in each stage by activators and 
inhibitors that are naturally produced by our immune system. Cellular migration, 
proliferation, matrix deposition and remodeling which causes progress in wound 
healing.(1) . Devitalized tissue and exudates act as mechanical barrier to migration 
of cells and provides an environment ideal for bacterial proliferation (2). Due to the 
presence of devitalized tissue there is excess production of pro-inflammatory 
cytokines and prolongation of inflammatory response (3). 
 
Thus wound bed preparation plays a crucial role in achieving a conducive 
environment for wound healing. There are various modalities available for wound 
debridement; most of these methods are covered in this review with major 
emphasis on enzymatic wound debridement with papaya. In my study, I have 
compared two debridement methods, one which we use regularly in our hospital, 
wet to dry normal saline dressing and enzymatic debridement with papaya.  
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AIM 
 
 
To  compare  the  effectiveness  of   papaya  versus  normal  saline  
debridement  in healing  of  ulcers. 
 
 
To evaluate the role of papaya dressing in wound debridement, granulation 
tissue formation, reduction in ulcer size and ulcer healing. 
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HISTORY 
 
• History of wound management dates back to 2200 B.C. (circa) in an ancient 
clay tablet which describes “Three healing gestures” 
1. Washing the wound  
2. Plaster making  
3. Wound bandage 
• In 2000 B.C., the Sumerians employed spiritual and physical methods in wound 
healing  
• In 1650 B.C., Ebers Papyrus describes use of concoctions containing honey, lint 
and grease in wound management (4). 
• In 1867 AD., Lister introduced the first antiseptic dressing using lint and gauze 
soaked in carbolic acid which impressed Robert Wood Johnson who improvised 
antiseptic dressing with cotton gauze impregnated with iodoform. 
• Earliest non adherent dressing which gained popularity in World War-I was 
gauze impregnated with paraffin tulle(5).  
In recent times many sophisticated and technically advanced dressing materials 
are available for wound care management. 
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DESIRABLE DRESSING MATERIAL 
 
Dressing should ideally protect the wounds from trauma, foreign bodies and 
bacterial contamination, should absorb the wound exudates, give good 
compression, reduce the dead space and minimize wound edema. 
• Dressing should provide a moist, warm occlusive environment to maximize 
epithelialization and reduce pain. 
• Importantly it should prevent heat and fluid loss from wounds especially with 
large surface area, e.g., burns  
• Non-adherent dressing is generally desirable as it limits wound disruption 
during change of dressings.  
Regardless of dressing materials all dressings should be aesthetically acceptable. 
But no single dressing has all these properties and also all wounds do not require 
all these functional properties (6). 
  
The concept of occlusive dressing has created a paradigm shift in wound 
management. In occlusive dressings there is two fold increase in rate of 
epithelialization when compared to wounds which were kept open and dry (7). 
Occluded moist environment provides a mildly acidic pH and low oxygen tension 
on wound surface. This low oxygen tension stimulates fibroblast proliferation and 
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granulation tissue formation (8, 9). Moisture in occlusive dressing facilitates 
angiogenesis and epidermal migration(10). Moisture also prevents desiccation and 
supports autolysis of necrotic material(11).  
Major disadvantage of placing an occlusive dressing is, it encourages 
bacterial proliferation and spread of infection in infected wounds. Wounds 
containing nonviable tissues and large exudative wounds that require high degree 
of absorption, occlusive dressing have no role. In these situations, dressing 
regimens containing antimicrobial activity and regimens that contribute to wound 
debridement are necessary. 
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WOUND HEALING - PATHOPHYSIOLOGY 
 
Wound healing or repair is an effort of the injured tissue to restitute its 
normal function and structural integrity after injury which involves a complex 
cellular and biochemical cascade. Normal wound healing involves three 
overlapping phases. 
1. Hemostasis & Inflammation 
2. Proliferation 
3. Maturation & Remodeling 
INFLAMMATORY PHASE (4 – 6 DAYS) 
This phase is characterized by stoppage of  bleeding, sealing of wound 
surface, removing bacteria and necrotic debris. Polymorphonuclear leukocytes 
appear after 48 hours and release inflammatory mediators and macrophages secrete 
fibroblastic growth factors. There is increased vascular permeability, migration of 
cells by chemotaxis, secretion of cytokines and growth factors into the wound. 
Chemical factors involved are, platelet derived growth factor, epidermal growth 
factor and transforming growth factor. Cytokines like TNF-α, Interleukin-1 & 
Interleukin-6. Enzymes like collagenase, elastase and prostaglandin-E2 play a 
major role in this phase.  
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PROLIFERATIVE PHASE (7 DAYS – 6 WEEKS) 
 
Characterized by angiogenesis, fibroplasia and formation of granulation 
tissue. Formation of  granulation tissue requires fibroblasts, macrophages, capillary 
bed, and loose arrangement of fibronectin, collagen and hyaluronic acid.  
 
 
MATURATION & REMODELING PHASE (6 WEEKS – 2 YEARS) 
 
Maturation phase is a result of complex interaction of extra cellular material 
and fibroblasts, leading on to wound contraction. Wound contracture reduces the 
amount of disorganized scar by centripetal movement of the surrounding skin. 
Matrix metaloprotein-3 appears to be a strong factor in wound contracture, which 
helps in breakdown of collagen. Wound strength and integrity ultimately depends 
on balance between collagen deposition and degradation(12).  
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CHRONIC WOUNDS - PATHOPHYSIOLOGY 
 
Chronic wounds are defined as, wounds that fail to proceed in the orderly 
process of healing and producing an unsatisfactory anatomical functional integrity. 
Chronicity of wounds is perpetuated by repeated trauma, hypoxia, poor perfusion 
and excessive inflammation. Unresponsiveness to normal regulatory stimulus of 
wound healing leading to failure of normal growth factor synthesis(13). 
 
In chronic wounds, it has been found that there is increased break down of 
growth factors with over expression of proteolytic activity and failure of normal 
antiprotease inhibitor mechanisms(14) . There is presence of senescent fibroblasts 
with poor proliferative potential and decreased growth factor receptor expression 
in chronic wounds(15).  
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DIABETIC WOUNDS 
 
Diabetic ulcers are the major contributors for chronic non-healing ulcers, 
which is attributed to neuropathy, foot deformity and ischemia in long standing 
diabetes. 60% to 70% diabetic ulcers are due to neuropathy and 15% to 20% are 
due to ischemia while the remaining are due to a combination of both these factors.  
 
Neuropathy in diabetes is both motor and sensory and it is due to persistently 
elevated glucose levels. Motor neuropathy leads to Charcot’s arthropathy, which is 
characterized by collapse of inter phalangeal or metatarsophalangeal joints causing 
pressure ulcers in unprotected areas. Sensory loss allows unrecognized injury due 
to trivial trauma, ill fitting footwear and foreign bodies. 
 
There is severe micro and macro vascular circulatory impairment 
contributing for local hypoxia. Once ulceration occurs, uncontrolled diabetes 
results in reduced inflammation, poor angiogenesis and collagen synthesis. There 
is an increased rate of wound infection and failure in diabetic wounds(16).  
There is defective granulocyte function, fibroblast proliferation and capillary 
ingrowth observed in diabetic wounds. Obesity, hyperglycemia and insulin 
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resistance individually and significantly contribute to impaired wound healing(17) . 
Wound healing significantly improves in patients with good glycemic control, 
inspired oxygen tension, appropriate antibiotics and correction of co-existing 
metabolic abnormalities(18). 
15 
 
WOUND DEBRIDEMENT:  AN OVERVIEW 
 
Henry Le Dran (1685 – 1770) was the first person to coin the term 
debridement in the context of an incision to promote drainage and relieve tension. 
It is derived from the French word meaning remove a constraint(19) . 
 
Debridement is defined as the act of removing necrotic material, foreign 
bodies, slough, puss, infected tissue, hematoma, hyperkeratosis, bone fragments or 
any other type of bio burden from wound, decrease odour, stimulate 
epithelialization and the  objective is to enhance wound healing and quality of 
life(20). Wound debridement is different from wound bed preparation, as 
debridement takes care of not only the wound bed but also wound edges and 
periwound skin which are a crucial factor for wound healing(21) .  
 
Modern day surgical practitioners use the TIME acronym to accurately 
assess the wound, infection, necrotic debris and plan of action.  
T - Tissue which is nonviable 
I - Infection or Inflammation 
M - Moisture Imbalance 
E - Edge whether non advancing or undermined(22) . 
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RATIONALE FOR DEBRIDEMENT 
 
 
• Reduction in Bacterial Burden 
• Removal of  Necrotic Debris 
• Activation of growth factors  
• Senescent cells from wound bed are removed  
• Non migratory cells from ulcer edge which hinders wound healing are 
removed  
 
Microorganisms contribute in a multifactorial way for impaired wound 
healing. In the presence of necrotic tissue, there is a high grade of bacterial 
proliferation, colonization of bacteria in wound beds leading to an altered 
inflammatory response, release of free oxygen radicals and proteolytic enzymes 
which cause tissue damage(23) . Proteases released by these microorganisms 
damages the growth factors and impair healing(24) .  
 
Exudate production causes degradation of extracellular matrix proteins and 
reduction in cellular proliferation(25) . Formations of biofilm due to communities of 
bacteria cause resistance to antibacterial treatment and tightly adhere to wound 
bed. Debridement effectively detaches these biofilms from wound bed(26) . 
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ACTIVATION OF GROWTH FACTORS 
 
Reduced availability of growth factors and deficient factors are seen in 
chronic wounds(27) . In altered wound healing pathways, growth factors become 
unavailable due to abnormal binding to matrix protein and necrotic tissue acts as 
physical barrier to growth factor receptor interaction (28) . Debridement results in 
fresh bleeding, activation of platelets, release of various growth factors, cytokines 
and fibronectin which are important essential components of good wound 
healing(29) .  
 
REMOVAL OF SENESCENT CELLS 
 
Senescent cells remain viable but they have a markedly decreased 
proliferation rate and poor response to growth factor stimuli. In chronic wounds, 
senescent fibroblasts have been present for longer duration and delay in wound 
repair. By debridement removal of these senescent cells is possible and results in 
production of viable cells in wound bed(30). 
In chronic wounds, the wound edges become thickened and contain non 
migrant hyper proliferative epithelium which hinders wound healing that can be 
removed by wound debridement(31).   
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WOUND DEBRIDEMENT METHODS 
• Surgical  /  Sharp Debridement 
• Mechanical and Technical solutions 
• Autolytic Debridement 
• Biological Debridement 
• Enzymatic Debridement 
 
SURGICAL & SHARP DEBRIDEMENT 
 
Surgical debridement is defined as procedure done under anaesthesia using a 
variety of surgical instruments. Sharp debridement is a minor bedside surgical 
procedure using scissors or scalpel to cut away tissues. Surgical debridement is 
generally used when rapid and major intervention is required.  
 
Indication for surgical debridement is when, there is a thick solid layer of 
necrotic tissue with a clear demarcation between viable and nonviable tissue. It is 
an important life saving procedure in case of severe wound infections(32 & 33). 
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BENEFITS OF SURGICAL DEBRIDEMENTS 
• Used in all types of wounds 
• Rapid and effective removal of necrotic tissue from wound and periwound 
site 
• Alternative to any other debridement methods 
• When immediate reconstruction is planned or when there is a possibility to 
close the wound 
 
LIMITATIONS OF SURGICAL DEBRIDEMENTS 
• There is always a risk of over excision and scarring 
• Damage to deeper structures, adjacent vessels, nerves and tendons 
• Special precaution must be taken while treating face, hands and perineum on 
account of functional and cosmetic outcome (34, 35 & 36). 
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MECHANICAL DEBRIDEMENT 
 
Mechanical debridement is a non selective physical method using 
mechanical force for debridement. Commonly used methods are, Wet to dry saline 
dressings, paraffin tulle and monofilament fibre pad. Technical solutions include 
whirlpool therapy, jet lavage system, vacuum assisted closure and ultrasound 
treatment.  
 
Wet to dry saline gauze dressing is the simplest method and most commonly 
used method which is used in our hospital setup. Normal saline (0.9%) soaked 
gauze is placed over the wound bed, as it dries top layers of the tissue in wound 
bed adheres to the dressing and mechanically removed when the dressing is 
changed. Limitations of wet to dry debridement, causes considerable pain and 
injury to normal tissue (37). It is time consuming and needs frequent dressing 
change with increased risk of infection(38). 
 
Monofilament fibre pad is a modern mechanical debridement product in 
which the necrotic debris is bound to the fibre component and there by removed 
from the wound bed. Fibre pad is wetted and wiped over the surface for 2 to 4 
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minutes (39 & 40). Advantages of monofilament fibre pad are rapid action with little 
to no pain and it does not remove the healthy granulation and epithelial islands(41). 
 
 
JET LAVAGE / WHIRLPOOL THERAPY: 
 
The principle behind this therapy is, powered irrigation with water which 
physically removes foreign bodies and loose necrotic tissues from the wound bed. 
Limitations are cost of these instruments, painful for some patients and may 
disseminate bacteria(42).  
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VACUUM ASSISTED NEGATIVE PRESSURE WOUND THERAPY: 
 
It is an indirect debridement technology, removes inflammatory exudates 
from wound, decrease wound edema, increase blood flow, increase wound 
contraction and protects the wound from external contamination (43).  
 
Primary limitations, it cannot be used in uncontrolled infections, in presence 
of necrotic tissue and local ischemia.  
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LOW FREQUENCY ULTRASOUND: 
 
Mechanism of action depends on the property of ultrasound, particular 
frequency and intensity of the mechanical energy interferes with structural proteins 
and cellular bodies and exerting a range of effects that may vary from destruction 
to dislocation and physical modification. Primarily it is used for debriding purpose 
and as an adjunct in reparative phase.  
 
                 Positive features of ultrasound is that, it can be used in different types of 
tissues, from loose connective tissues to tendons and even bones with high level of 
effectiveness. It destroys microorganisms and disruption of biofilms.  
 
      Limitations of ultrasound – related to difficulty in production of reliable 
and affordable devices that can be safely applied in wounds with satisfying results 
(44).  
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AUTOLYTIC DEBRIDEMENT: 
 
Autolysis is a natural and highly selective process of removing necrotic 
tissue from wound bed by utilizing proteolytic enzymes in the presence of 
moisture(45). They have a dual mode of action in wound therapy as in they donate 
water to dry wounds and absorb fluids from moderately exudative wounds.  
 
Endogenous proteolytic enzymes like collagenase, elastase, 
myeloperoxidase, acid hydroxylase are released and activation of phagocytes 
occurs. These enzymes soften, dissolve and breakdown necrotic or sloughy tissue 
in the wound, enabling macrophages to digest them. Another aspect of autolytic 
dressing is, they cause swelling of necrotic tissue and fibrin coatings facilitating 
their detachment(46).  
 
Hydrogels, hydrofibres, hydrocolloids, multifunctional polymer membrane 
formation, multicomponent dressings (hydrated alginate polymers – contains 
autolytic, antimicrobial and absorptive features) and hydration response technology 
are some of the methods of autolytic debridement in use. Different products are 
available for varying levels of exudate. 
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Hydrogels or hydrogel based dressings are cross linked homopolymers with 
a three dimensional structure, saturated with water.Water content in hydrogel 
dressings proportionately vary from 30% to 90%. 
 
Hydrocolloids are adhesive compounds that turn into a gel when they come 
into contact with wound exudate. These compounds are composed of carboxy 
methyl cellulose, pectin, gelatin and elastomers.For autolytic debridement, a moist 
wound milieu should be created for optimizing leucocyte and macrophage activity. 
 
INDICATIONS: 
• Acute and chronic wounds with necrotic tissue or fibrin coatings 
• Soften and liquefy hard eschar and slough 
• Dry wounds requiring hydration 
 
BENEFITS OF AUTOLYTIC DEBRIDEMENT: 
• Easy to use & cause little to no pain. 
• Promote formation of granulation tissue and epithelialization. 
• Does not damage healthy granulation tissue. 
• Fewer dressing change needed. 
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DRAWBACK OF AUTOLYTIC DEBRIDEMENT: 
• It takes a longer period for wound healing 
• Can only be used for infected wounds which are under control 
• Contraindication – Contact sensitization to ingredients of the 
dressings(47). 
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BIOLOGICAL DEBRIDEMENT: 
 
Live maggots cultured in sterile conditions, usually Lucilia sericata 
(common green bottle fly) is placed on necrotic wounds. Maggots secrete anti-
bacterial substances that reduce bacterial load and release trypsin like proteolytic 
enzymes which cause eschar degradation by digesting the collagen matrix. They 
promote wound healing and amplify human fibroblast and chondrocyte growth(48). 
 
Larval therapy has been in use for the past 400 years and primarily used 
when traditional methods are unsuccessful. 24 to 48 hours old sterile larvae (10 to 
15 per Sq Cm of wound) applied twice a week and placed for 24 to 72 hours (49). 
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BENEFITS OF BIOLOGICAL DEBRIDEMENT: 
 
• Reduces pain, bacterial load and malodour. 
• Promotes wound healing with little or no side effects. 
• Maggot separate necrotic tissue from live tissue allowing for an easier 
sharp debridement. 
• Easy to apply and use of biobags containing larvae are aesthetically 
acceptable for the patients. 
    
 
 
CONTRAINDICATIONS: 
 
• Not to be used in wounds near upper gastrointestinal tract, upper 
respiratory tract and eyes.  
• Patients with allergy for fly larvae are soy-bean protein.  
• Not suitable for wounds with exposed blood vessels potentially 
connecting to vital organs 
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Only limitation is that the patient should be psychologically prepared to 
experience maggots’ debridement therapy. 
 
There is a re-emergence in the usage of larval therapy due to rise in chronic 
non healing wounds and emergence of antibiotic resistant bacterial strains in recent 
years. 
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ENZYMATIC DEBRIDEMENT 
 
Enzymatic debridement has been in practice for few hundred years in the 
treatment of sloughed out necrotic wounds. It is a highly selective method of 
wound debridement which uses proteolytic enzymes that work synergistically with 
endogenous enzymes and enhance wound repair (50). 
 
MECHANISM OF ACTION: 
  
Proteolytic enzymes hydrolyze peptide bonds and facilitate removal of 
necrotic tissue from wound bed. These enzymes are divided into endopeptidases 
and exopepsidases. Endopepsidases digest peptide bonds and exopeptidases 
hydrolyze amino or carboxy terminals of proteins (51). Bacterial proteolytic 
enzymes that are commonly used in enzymatic debridement are collagenase, 
streptokinase, streptodornase and sutilain. Animal proteolytic enzymes used in 
debridement are collagenase, catalase, krill multienzyme complex, fibronolysin 
and deoxyribonuclease .Plant proteolytic enymes are papain from Carica papaya 
and bromelain enzyme complex from pineapple (52). 
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PAPAYA IN ENZYMATIC DEBRIDEMENT  
 
The concept of using the latex of papaya fruit for enzymatic debridement 
relates to the practice of natives in tropical countries who used the latex to treat 
skin conditions like warts, eczema and ulcers (53). The very peculiar phenomenon 
of the fruit is that the scraped part of the fruit healed immediately without any scar 
marks.  The wound healing property of papaya is attributed to the endolytic plant 
enzyme papain (54).  
 
Latex from raw papaya fruit is rich in papain. Papain has an extensive 
proteolytic activity, breaks down short chain peptides, amide links and amino acid 
esters. Papain has a preference to cleave peptide bonds involving basic amino acids 
and in particular arginine and lysine (55). 
 
PHYTOCHEMICAL COMPONENTS IN PAPAYA 
  
Latex of Carica papaya fruit contains four cysteine endopeptidases namely 
papain, chymopapain, glycyl endopeptidase and carcain (a papaya endopeptidase-
II) (56). As the fruit ripens papain and chymopapain gets degraded and ripe fruits 
doesn’t contain these two enzymes (57). Other components include endopeptidase-
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IV, omegaendopeptidase, class-II and class-III chitinase and a serine protease 
inhibitor (58 & 59). 
 
CHEMICAL STRUCTURE OF PAPAIN: 
  
Papain is a globular protein with molecular weight of 23406 DA. Contains 
212 amino acids with disulphide bridges and catalytically important glycine-19, 
cystiene-25, histidine-158 and159 residues (60). Optimum pH for activity of papain 
is 3.0 to 9.0 (61). Papain is usually defiant to high concentrations of denaturing 
agents and it is very stable even at high temperatures (62). Papain is stabilized by 
three disulphide bridges and its three dimensional structures contain two distinct 
structural domains with an active catalytic diad in the cleft between the domains 
similar to the structure of chymotrypsin. 
 
MECHANISM OF ACTION OF PAPAIN: 
  
Proteolytic action involves cleavage of polypeptide chains and hydrolysis of 
collagen cross linkages. It doesn’t act on normal tissue as it acts only on tissues 
lacking α-1 antitrypsin plasmatic antiprotease that inhibits proteolysis in healthy 
tissues (63). 
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 Cysteine-25 portion is the active site that attacks the carbonyl carbon in the 
peptide chain, releasing the amino terminal portion. This feature occurs throughout 
the peptide chain resulting in the breakdown of protein. Deprotonation of cysteine-
25 by histidine-159 and aspargine-175 assists to align the imidazole ring of 
histidine-159 to allow this deprotonation to occur. The unique proteolytic function 
of papain lies in the coordinated action of this three aminoacids in the active 
site(55).  
 
WOUND HEALING PROPERTY OF PAPAYA: 
 
Enzymes mainly papain and chymopapain have fibrinolytic activity and 
assist in removal of slough and necrotic tissue from wound bed. Papaya induces 
development of healthy granulation tissue, as the fruit is rich in vitamin C which 
helps in conversion of proline to hydroxyproline which is a specific indicator of 
collagen content laid during wound healing (64). 
 
It has a potent bactericidal action attributed to an aglycone benzyl 
isothiocyanate and glycoside-glucotropaelin. These agents have been proven to be 
active against Bacillus cereus, E.coli, Shigella flexneri, Staphylococcus aureus, and 
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Pseudomonas. This antibacterial action has been attributed for its healing potential 
in paediatric burns wound.  
 
Papaya extract breaks down the biofilm defenses, as this biofilm gives 
protection to bacteria from ultraviolet rays and oxygenation .Bacteria in chronic 
wounds live within these biofilm communities protecting them from host immune 
response (65). 
 
Commercial preparations of papain in combination with other chemical 
agents have been in use. Most commonly used preparation is papain urea 
(debridase). This combination is used, as urea increases the proteolytic action of 
papain by reducing disulphide bridges and making the protein more susceptible for 
its action. Other preparation in the market is papain urea chlorophylline copper 
complex which acts by inhibiting hemaglutination, inflammatory properties of 
protein degradation and decreases pain and wound odour (66). 
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OTHER MEDICINAL PROPERTIES OF CARICA PAPAYA PLANT: 
  
Papaya leaves, seeds, latex and fruit have been proved to have medicinal 
value due to a wide range of unique properties including anti-inflammatory, free 
radical scavenging, anti-oxidant, antiviral, anti-diabetic and anti-hypertensive 
properties (67). 
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MATERIALS & METHODS 
 
This is a randomized, comparative interventional study carried out in 
Kilpauk Medical College Hospital from August’ 2013 to August’ 2014. The study 
was approved by the Institution ethical committee. The study group comprised of 
hundred patients with ulcers due to diabetes mellitus, wound infections and post 
operative wound dehiscence.  
Patients were selected, randomized and divided into two groups. 
• Group-1: 50 patients treated with papaya dressing 
• Group-2: 50 patients treated with wet to dry normal saline dressing.  
 
METHOD OF DATA COLLECTION: 
 
• Clinical assessment done during time of inclusion 
• Complete history and detailed examination done at inclusion 
• Ulcer and devitalized tissue accurately assessed 
• Measurement of ulcer using sterile gauze and graph paper 
• Area of ulcer calculated in Sq.Cm 
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INCLUSION CRITERIA: 
 
• Patients aged more than 20 years with diabetic ulcers and infected ulcers. 
• Wagners ulcer grade-II and grade-III 
• Post operative wound dehiscence 
 
WAGNERS ULCER GRADE 
• Grade-I: Superficial ulcers 
• Grade-II: Deep ulcers upto subcutaneous tissue exposing soft tissue or 
bone 
• Grade-III: Abscess formation underneath / osteomyelitis. 
• Grade-IV: Gangrene of part of tissue / limb / foot. 
 
EXCLUSION CRITERIA: 
 
• Ulcers with severe active infections  
• Wagners ulcer grade more than III 
• X-Ray features of underlying osteomyelitis 
• Diabetic foot with major vascular disease 
• Uncontrolled diabetes mellitus 
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• Patients with hepatic, renal and hematological diseases which impair 
wound healing 
• Patients on immunosuppressive drugs, long term steroid therapy, radio 
therapy or chemotherapy. 
 
INVESTIGATIONS: 
 
• Complete blood count  
• FBS and PPBS 
• Renal function test 
• Liver function test 
• Wound culture and sensitivity 
• X-Ray of involved part  
• Duplex scan, if vascular compromise is suspected 
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TREATMENT PHASE: 
 
• Patients were randomized using computer generated random table after 
stabilization of ulcer. 
• All patients during initial treatment phase underwent surgical 
debridement and devitalised tissue was removed. 
• Daily cleaning and dressing done till ulcer became stable (i.e., no 
progression in size of ulcer) 
• Good glycemic control was achieved in diabetic patients and maintained 
throughout the treatment phase. 
• Culture and sensitivity was done during the phase and appropriate 
antibiotics were started.  
• Patients were assessed at 0(randomization), 1, 2, 3, 4 weeks and reviewed 
after three months. 
• Reduction in slough, reduction in ulcer size and progression in healthy 
granulation tissue formation noted weekly. 
• Induration, discharge and odour were noted weekly during this phase.  
• Safety and tolerability of the study was closely monitored and assessed 
by questioning the patients regarding pain, itching and hypersensitivity 
reaction during the treatment phase. 
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• Control group received wet to dry gauze dressing application with sterile 
gauze soaked with normal saline (0.9%) over the wound. Extra layers of 
abdominal pad placed over the moist gauze and twice daily dressing 
change was done (68).  
• In the study group, ulcers were cleaned with normal saline and washed 
thoroughly. Semi ripe papaya was selected for all patients, washed and 
epicarp of the fruit was pealed and the fruit was grated finely and mashed 
into a paste and applied over the wound under sterile precaution (69). Dry 
gauze was placed over the wound and dressing was applied.  
• All the patients were treated till complete debridement.  
• The reduction in slough and reduction in wound size in Sq.Cm. was 
assessed weekly from zero to four weeks. Granulation tissue formation in 
comparison to wound size was measured in percentage weekly till 
complete granulation. End point was presence of 100% healthy 
granulation tissue which was defined as pink tissue with beaded and 
granular appearance. 
• At the end point, whether any secondary procedure like SSG or 
secondary suturing if done was noted and follows up was done for three 
months. 
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METHODS: 
 
 Study was initially started in 128 patients, 64 patients in each group after 
randomization. 
  
• 16 patients lost follow up after treatment phase 
• 3 patients died during the follow up phase (2 patients died of CVA & 1 
patient died of MI) 
• 5 patients went against medical advice during treatment phase 
• There were remaining 104 patients, 53 patients in papaya group and 51 
patients in normal saline group. First 50 patients in each group in the random 
table were taken into the study for comparison. 
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STATISTICAL METHODS: 
 
• Probability value (P Value) < 0.05 the null hypothesis was rejected i.e., P 
Value < 0.05 means there is significant relationship between the two tests. 
• Student’s t-test (t-test) was used to find the difference between means of the 
two groups.  
• Chi square (ݔଶሻ test was used to find difference between percentages or 
proportions of categorical outcomes of the two groups. 
• Other non parametric test used to find the significance was Fisher’s exact 
test. 
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Clinical Photographs 
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Data Analysis & Results 
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DISTRIBUTION OF PATIENTS IN THE STUDY GROUP 
 
 
 
 
 
• 58% of the patients were diabetic in the study group. 
• 35% were non-diabetic.  
• 7% had post operative wound dehiscence. All were non-diabetic.  
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TABLE 1: MEAN AGE DISTRIBUTION IN THE STUDY  
 
 
 
 
 
 
Group N Mean Std.Dev Minimum Maximum t-value p-
value 
PAPAYA 50 57.6 9.4502 34 80 
-1.9 0.0604 NORMAL 
SALINE 
50 54.2 8.4201 37 71 
TOTAL   55.9 8.93515 36 76 
 
 
 
• Mean age in papaya group was 57.6 +/- 9.4502 yrs. 
• Mean age in normal saline group was 54.2 +/- 8.4201 yrs. 
• There was no significant difference between the two groups. 
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TABLE 2 : SEX DISTRIBUTION IN THE STUDY 
 
 
 
 
SEX 
DRESSING Chi-
square 
value 
P-value 
NORMAL 
SALINE PAPAYA Total 
MALE 
28 27 
55 
0.0404 0.8407 
56% 54% 
FEMALE 
22 23 
45 44% 46% 
Total 50 50 100 
 
• In papaya group : 54% males and 46% females  
• In normal saline group : 56% males and 44% females.  
• No significant difference between groups with  respect to 
gender noted. 
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TABLE 3: DIABETES DISTRIBUTION IN THE STUDY 
 
 
Diabetes 
status 
Dressing Chi-square 
value 
P-value 
NORMAL 
SALINE PAPAYA Total 
YES 
28 30 
58 
0.1642 0.6853 
56% 60% 
NO 
22 20 
42 
44% 40% 
Total 50 50 100 
 
• The study has 58 diabetes patients and 42 non-diabetes patients  
• In papaya group :  60% diabetic patients and 40% non-diabetes patients 
• In normal saline group : 56% diabetes patients and 44% non-diabetes 
patients 
• No significant difference between groups with respect to diabetes 
patients noted. 
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TABLE 4: DISTRIBUTION OF SITE OF ULCER IN THE STUDY 
 
 
• Shows the study has 30% have ulcer in right foot and 29% have ulcer in left 
foot. 
• Totally 59% have ulcer in lower limbs. 
• Other 41% have ulcer in other areas like thighs, back, arms, scrotum and 
abdomen. 
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TABLE 4: DISTRIBUTION OF SITE OF ULCER IN THE STUDY 
SITE OF ULCER 
DRESSING 
NORMAL 
SALINE PAPAYA Total 
ABDOMEN 
4 1 
5 
8% 2% 
LEFT ANKLE 
0 1 
1 
0% 2% 
LEFT ARM 
1 1 
2 
2% 2% 
LEFT FOOT 
16 14 
30 
32% 28% 
LEFT GLUTEUS 
0 1 
1 
0% 2% 
LEFT LEG 
2 3 
5 
4% 6% 
LEFT THIGH 
0 2 
2 
0% 4% 
RIGHT ANKLE 
2 3 
5 
4% 6% 
RIGHT ARM 
1 0 
1 
2% 0% 
RIGHT ELBOW 
1 1 
2 
2% 2% 
RIGHT FOOT 
14 15 
29 
28% 30% 
RIGHT GLUTEUS 
0 1 
1 
0% 2% 
RIGHT HIP 
1 2 
3 
2% 4% 
RIGHT LEG 
5 3 
8 
10% 6% 
RIGHT THIGH 
2 0 
2 
4% 0% 
RIGHT UPPER BACK 
0 1 
1 
0% 2% 
SCROTUM 
1 1 
2 
2% 2% 
Total 50 50 100 
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TABLE 5: MEAN DURATION OF ULCER BEFORE TREATMENT 
 
 
 
 
 
Group N Mean Std Minimum Maximum t-value P-value 
PAPAYA 50 7.56 2.5964 3 15 
0.04 0.9647 NORMAL 
SALINE 50 7.58 1.8416 4 12 
TOTAL 100 7.57 2.219 4 9 
 
 
• Mean duration of ulcer in papaya group was 7.56  +/- 2.5964 days. 
• Mean duration of ulcer in normal saline group was 7.58 +/- 1.8416 days. 
• There was no significant difference between the two groups. 
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TABLE 6: CULTURE AND SENSITIVITY PATTERN IN THE STUDY 
 
 
C/S 
Dressing 
NORMAL SALINE PAPAYA Total 
E.COLI 
6 8 
14 
12% 16% 
KLEBSIELLA 
5 6 
11 
10% 12% 
S.AUREUS 
5 4 
9 
10% 8% 
PROTEUS 
4 4 
8 
8% 8% 
PSEUDOMONAS 
2 3 
5 
4% 6% 
NO GROWTH 
28 25 
53 
66% 50% 
Total 50 50 100 
 
• Culture and sensitivity patterns in both groups were similar. 
• Most frequently grown organism was E.coli followed by Klebsiella. 
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TABLE 7: DISTRIBUTION OF MEAN ULCER SIZE IN THE STUDY 
 
 
 
Group Time point N Mean Std Minimum Maximum t-value P-value 
PAPAYA Week 1 34 0.8929 0.4081 0.32 2.11 12.76 <.0001 
  Week 2 49 1.63 0.9775 0.32 4.37 11.67 <.0001 
  Week 3 50 2.5062 1.504 0.5 7.32 11.78 <.0001 
  Week 4 50 3.6966 2.1057 0.86 10.12 12.41 <.0001 
                  
NORMAL 
SALINE Week 1 31 0.9087 0.4735 0.32 2.08 10.69 <.0001 
  Week 2 49 1.4339 0.9097 0.33 4.33 11.03 <.0001 
  Week 3 50 2.1564 1.2961 0.52 6.24 11.76 <.0001 
  Week 4 50 3.0306 1.7232 0.89 8.47 12.44 <.0001 
 
• Mean ulcer sizes in both groups were similar. 
• Both groups showed reduction in ulcer size over the 4 weeks period. 
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TABLE 8: SLOUGH/NECROTIC TISSUE REDUCTION WITHIN THE STUDY 
 
 
Group Time point N Mean Std Minimum Maximum 
Difference 
from 
baseline 
p-value 
NORMAL 
SALINE Baseline 50 62.64 9.5335 40 78     
  Week 1 50 45.88 8.2329 21 62 -16.76 <.0001 
  Week 2 50 32.46 6.792 12 54 -30.18 <.0001 
  Week 3 49 19.9388 5.297 10 32 -43.1633 <.0001 
  Week 4 32 13.1563 3.4558 8 20 -51.1875 <.0001 
                  
PAPAYA Baseline 50 64.02 11.6488 32 84     
  Week 1 50 42.26 9.6549 21 68 -21.76 <.0001 
  Week 2 50 25.68 9.0225 8 43 -38.34 <.0001 
  Week 3 33 15.5455 4.8676 10 34 -51.2727 <.0001 
  Week 4 2 10.5 0.7071 10 11 -61 0.0482 
 
• There was significant difference in percentage reduction in slough / necrotic 
tissue within the two groups. 
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TABLE 9: SLOUGH/NECROTIC TISSUE REDUCTION BETWEEN THE 
STUDY GROUPS 
 
  NORMAL SALINE PAPAYA     
Time point N Mean N Mean Difference p-value 
Baseline 50 62.64 50 64.02 -1.38 0.5183 
Week 1 50 45.88 50 42.26 3.62 0.0464 
Week 2 50 32.46 50 25.68 6.78 0.0494 
Week 3 49 19.9388 33 15.5455 4.3933 0.0003 
Week 4 32 13.1563 2 10.5 2.6563 0.0082 
 
• There was significant difference in reduction in slough/necrotic tissue 
between the two groups. 
• In the second week comparison p-Value was 0.049, third week it was 0.0003 
and the fourth week it was 0.0082. 
• Papaya group showed better slough reduction in 2nd, 3rd and 4th weeks 
compared to normal saline. 
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TABLE 10: DISTRIBUTION OF WEEKWISE GRANULATION TISSUE 
FORMATION IN THE STUDY 
 
  NORMAL SALINE PAPAYA     
Time point N Mean N Mean Difference p-value 
Baseline  32 12.25 37  12.3514 -0.1014 0.9013 
Week 1  50 26.92 50  33.66 -6.74 0.0008 
Week 2  50 46.82 50  59.22 -12.4 <.0001 
Week 3  50 66.66 50  81.9 -15.24 <.0001 
Week 4  50 85.9 41  95.0976 -9.1976 <.0001 
Week 5  40 97.55 16  98.875 -1.325 0.2704 
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TABLE 10: DISTRIBUTION OF WEEKWISE GRANULATION TISSUE 
FORMATION IN THE STUDY 
 
• There was significant difference in percentage increase in granulation tissue 
in papaya group compared to normal saline group.  
• Week  wise  comparison  between  the  two  groups  showed  that  papaya  
showed better granulation tissue formation after  2nd , 3rd & 4th weeks when 
compared to normal saline group. 
• p-Value was less than 0.0001 at the end of 4th week. 
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TABLE 11: DISTRIBUTION OF REDUCTION OF ULCER SIZE IN THE 
STUDY 
 
  NORMAL SALINE PAPAYA     
Time point N Mean N Mean Difference p-value 
Week 1 31 0.9087 34 0.8929 0.0158 0.8858 
Week 2 49 1.4339 49 1.63 -0.1961 0.3065 
Week 3 50 2.1564 50 2.5062 -0.3498 0.2158 
Week 4 50 3.0306 50 3.6966 -0.666 0.0866 
              
 
• Week wise comparison of reduction in size of ulcer of ulcer did not show 
any significant difference. 
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TABLE 12: SLOUGH/NECROTIC TISSUE REDUCTION IN DIABETES VS NON-
DIABETES PATIENTS IN PAPAYA GROUP 
 
Diabetes 
status 
Time 
point N Mean Std Minimum Maximum 
Difference 
from 
baseline 
p-value 
Yes Baseline 30 63.5333 12.0594 32 84     
  Week 1 30 43.1 10.2363 21 68 -20.4333 <.0001 
  Week 2 30 28.2667 9.3769 8 43 -35.2667 <.0001 
  Week 3 24 15.6667 5.3703 10 34 -50.75 <.0001 
  Week 4 2 10.5 0.7071 10 11 -61 0.0521 
                  
No Baseline 20 64.75 11.2712 42 78     
  Week 1 20 41 8.8139 26 54 -23.75 <.0001 
  Week 2 20 21.8 7.0233 12 33 -42.95 <.0001 
  Week 3 9 15.2222 3.4197 11 20 -52.6667 <.0001 
  Week 4 0             
 
 
• There is no significant difference in reduction of slough/necrotic tissue 
between diabetes and non-diabetes patients. 
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TABLE 13: DISTRIBUTION OF GRANULATION TISSUE FORMATION IN 
DIABETES VS NON-DIABETES PATIENTS IN PAPAYA GROUP 
 
 
 
Diabetes 
status 
Time 
point N Mean Std Minimum Maximum 
Difference from 
baseline 
Yes Baseline 23 12.1304 3.8412 6 19 
Week 1 30 32.1667 11.0706 12 57 24.3913 
Week 2 30 56.9667 11.4786 34 79 48.4783 
Week 3 30 78.6667 10.8924 56 100 68.087 
Week 4 28 94.2143 7.4851 79 100 82.8571 
Week 5 12 98.5 3.5291 90 100 89.3333 
No Baseline 14 12.7143 2.9982 8 19 
Week 1 20 35.9 12.0783 14 58 28.5 
Week 2 20 62.6 11.2034 42 78 52.2143 
Week 3 20 86.75 11.5434 60 100 75.0714 
Week 4 13 97 4.761 88 100 82.25 
Week 5 4 100 0 100 100 87.75 
 
• There is no significant difference in formation of granulation tissue between 
diabetic and non diabetic patients.  
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TABLE 14: REDUCTION OF ULCER SIZE IN DIABETES Vs NON-
DIABETES PATIENTS IN PAPAYA DRESSING 
 
 
 
• There was no significant reduction in ulcer size between diabetic and non 
diabetic patients. 
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Diabetes Status Time point N Mean Std Minimum Maximum t-value 
Yes Week 1 20 0.964 0.4304 0.41 2.11 10.02 
  Week 2 29 1.709 1.0265 0.4 4.37 8.97 
  Week 3 30 2.6383 1.5577 0.5 7.32 9.28 
  Week 4 30 3.919 2.1519 0.86 10.12 9.98 
                
                
No Week 1 14 0.7914 0.365 0.32 1.54 8.11 
  Week 2 20 1.5155 0.9152 0.32 3.16 7.41 
  Week 3 20 2.308 1.4357 0.84 5.27 7.19 
  Week 4 20 3.363 2.0424 1.12 8.31 7.36 
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TABLE 15: PERCENTAGE REDUCTION IN SLOUGH / NECROTIC TISSUE 
FROM BASELINE 
 
 
 
 
  NORMAL SALINE PAPAYA     
Time point N Mean N Mean Difference p-value 
Week 1 50 -26.7402 50 -33.8116 7.0714 0.0001 
Week 2 50 -48.0757 50 -60.011 11.9353 <.0001 
Week 3 50 -68.8044 50 -84.4574 15.6531 <.0001 
Week 4 50 -86.7518 50 -99.4085 12.6567 <.0001 
              
 
 
• There was significant difference in percentage reduction in slough necrotic 
tissue in papaya group compared to normal saline group.  
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TABLE 16: REDUCTION IN SLOUGH/NECROTIC TISSUE  
 
 
 
Complete disappearance of 
slough tissue NORMAL SALINE PAPAYA 
p-value (fisher 
exact test) 
  N (%) N (%)   
Week 3       
Yes 1 (2.0) 17 (34.0) 
<.0001 No 49 (98.0) 33 (66.0) 
        
Week 4       
Yes 18 (36.0) 48 (96.0) 
<.0001 No 32 (64.0) 2  (4.0) 
        
 
 
• Disappearance of slough/necrotic tissue was more significant in papaya 
group in  3rd and 4th week when compared to normal saline group. 
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TABLE 17: MEAN FOLLOW UP AMONG THE STUDY GROUP AFTER 3 
MONTHS 
 
Status 
Dressing 
Chi-square  p-value NORMAL 
SALINE  PAPAYA Total 
HEALED 
36 39 
75 
0.48 0.4884 
72% 78% 
HEALING 
14 11 
25 
28% 22% 
Total 50 50 100 
 
 
• At third month follow up showed 78% of wounds treated with papaya were 
completely healed and 22% were healing. 
• 72% of wounds treated with normal saline were completely healed and 28% 
were healing.  
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TABLE 18: ADDITIONAL TREATMENT: SSG / SECONDARY SUTURING 
 
 
 
ADDITIONAL 
TREATMENT 
Dressing 
NORMAL SALINE PAPAYA Total 
HEALED 23 27 50 46% 54% 
SSG 22 19 41 44% 38% 
SEC. SUTURING 5 4 9 10% 8% 
Total 50 50 100 
 
• 22 patients underwent SSG in normal saline group and 19 patients in papaya 
group  
• 5 patients underwent secondary suturing in normal saline group and 4 
patients in papaya group 
• 23 patients in normal saline group and 27 patients in papaya group did not 
require any additional treatment. 
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Discussion 
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DISCUSSION 
 
Enzymatic chemical debriding agents like collagenase, pure papain and 
papain urea combinations have been in practice for wound bed preparation. 
Enzymatic debridement with papaya is a cost effective , easily available and is eco 
friendly also. 
 
A detailed literature search revealed several anecdotal reports, various 
review articles and few methodical studies which have analyzed the enzymatic 
action of papaya fruit, in diabetic ulcers, post operative wound dehiscence in 
western population and in diabetic rats. Based on these reports, it was decided to 
study the effects of papaya in wound bed preparation.  
Our study results have shown that there is significant difference (p-Value < 
0.001) in granulation tissue formation with papaya dressing when compared to 
normal saline dressing in third and fourth weeks. This is attributed to granulation 
tissue formation induced by Papain and chymopapain. Slough reduction with 
papaya was also significant, as 96% of the patients were completely cleared of 
slough at the end of fourth week, when compared to 36% with normal saline 
dressing. The p- value was (0.0082) significant during second, third and fourth 
week of the papaya dressing. 
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 There was no significant reduction in ulcer size ( p-value of 0.086) when 
compared to normal saline. Reductions in ulcer size in both groups were similar. In 
well controlled diabetes mellitus, papaya can be used as a debriding agent safely. 
Wet to dry normal saline dressings is routinely employed for wound dressings, as it 
is cost effective and easily available. But in comparison to papaya it takes a longer 
duration for healing and time consuming. 
 
There was no hypersensitivity, tolerability or side effects in both the groups, 
as previous studies have already confirmed the safety and tolerability aspects of 
papaya. It has been reported that some pure papain preparations have been 
associated with pain, itching and hypersensitivity reactions. Despite such concerns 
no such hypersensitivity was seen in this study. Patient has to be clearly instructed 
to use semi ripe papaya since raw papaya application is associated with pain.  
 
 
Limitations of this study are related to lack of standardized methods of 
papaya preparation. The enzymatic content of papaya is said to decrease as fruit 
ripens, suggesting a better efficacy in semi ripe papaya. In spite of difference in 
enzyme content as the fruit ripens, previous studies confirm that there is no 
difference is in antibacterial activity in ripe and unripe fruit.  
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Papaya dressing can be encouraged as papaya is easily available in India 
throughout the year and cost effective also. Preparation and application of papaya 
dressing is also easy and can be done by unskilled personnel.  Thus in terms of 
efficacy, papaya dressing can be a good and better dressing method compared to 
normal saline dressing. 
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Conclusion 
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CONCLUSION 
 
• Papaya dressing and normal saline dressing have proven efficacy in 
debridement of wounds. 
• Papaya dressing is a better enzymatic agent when compared to wet to dry 
normal saline mechanical debridement. 
• Papaya dressing was found to remove slough and necrotic tissue more 
rapidly when compared to normal saline as per our study. 
• Wounds treated with papaya dressing had a faster granulation tissue 
formation compared to normal saline dressing. 
• There was no significant difference in reduction in ulcer size between the 
two groups in this study. 
• Overall response to treatment with papaya dressing was significantly better 
when compared to normal saline dressing. 
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PROFORMA 
 
 
NAME     : 
AGE     : 
SEX     : 
IP NUMBER    : 
SOCIO ECONOMIC STATUS : 
CHIEF COMPLAINTS   : 
COMORBID CONDITIONS  : 
PAST HISTORY   : 
 
 
ULCER (Examination ): 
• Duration 
• Site 
• Size 
• Number 
• Discharge 
• Margins & edges 
• Induration 
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INVESTIGATIONS: 
• Haemoglobin 
• Total counts 
• Differential counts 
• RFT 
• LFT 
• Culture & Sensitivity 
• X Ray ( if required ) 
 
TYPE OF DRESSING: 
• Papaya 
• Normal saline 
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ASSESSMENT OF TREATMENT: 
 
 1st Week 2nd Week 3rd Week 4th Week 
Reduction in size 
 
    
Reduction in slough 
 
    
Granulation tissue 
 
    
Over-all clinical 
response 
 
    
Side Effects 
 
    
Total follow up 
 
    
Additional treatment 
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